| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Divisions of Infection, Inflammation, and Repair,*Cellular Pathology,and Cancer Sciences,University of Southampton, Southampton General Hospital, Southampton, United Kingdom
 |
Abstract |
|---|
 Top Abstract Materials and MethodsResultsDiscussionReferences |
|---|
-smooth muscle actin (-SMA), proliferate, and secrete fibrillar collagens, including collagen I, that characterize chronic pancreatic fibrosis. As such the PSCs probably represent the wound-healing myofibroblasts of the pancreas.1 The matrix metalloproteinases (MMPs) are a family of calcium-dependent proteinases, which have an important role in extracellular matrix degradation.5,6 The accumulation of extracellular matrix may result not only from increased synthesis but also from changes in the pattern of repair and degradation. MMP-2 and MMP-9 (gelatinase A and B, respectively) may be particularly important in regulating fibrogenesis and scar degradation. They degrade partially degraded collagens I and III (gelatins) and basement membrane collagen (collagen IV). Although these gelatinases require the initial activity of interstitial collagenases such as MMP-1 or MMP-13, recent studies suggest that a wider range of MMPs including the gelatinases and membrane type-1 (MT1)-MMP have interstitial collagenolytic activity.7 MMP-3 (stromelysin 1) also exhibits the ability to degrade a broad range of substrates such as collagen III, IV, gelatins, laminin, and MMP-3 itself may activate MMP-1, which plays an important role in the cleavage of native interstitial collagens.8 The activity of MMPs is regulated at the levels of transcription, proenzyme activation, or inhibition of activated enzyme by tissue inhibitors of metalloproteinases (TIMPs).9,10 PSCs may play a central regulatory role in pancreatic fibrosis by controlling matrix degradation in chronic pancreatitis through the expression of MMPs and TIMPs. Transcriptional regulation of MMPs and TIMPs is mediated by cytokines and growth factors.
Transforming growth factor-ß (TGF-ß) plays a pivotal role in the development of fibrosis in the liver and other organs.11-14 TGF-ß is a member of a family of dimeric polypeptide growth factors and three isoforms have been described in mammals: TGF-ß1, TGF-ß2, and TGF-ß3. As a family TGF-ßs have a wider role in regulation for cell growth and differentiation.15 TGF-ß regulates these cellular processes by binding to three high-affinity cell-surface receptors types I, II, and III. The receptors type I and II are linked to serine-threonine protein kinases and after ligand stimulation,16 intracellular signaling is initiated via transcription factors known as SMADs.17 TGF-ß1 up-regulates collagens, TIMP-1, and MMP-2 while down-regulating TIMP-2, interstitial collagenases, and stromelysins in fibroblasts.18-20 Increasing evidence suggests that PSCs also can be activated by paracrine profibrogenic cytokines such as platelet-derived growth factor and TGF-ß derived from migrating macrophages.21 Moreover, PSCs produce ECM components in response to TGF-ß suggesting that this cytokine has an important role in pancreatic fibrogenesis.1,22
In both human and experimental pancreatic fibrosis, TGF-ß has been observed in the atrophic acinar cells adjacent to areas of fibrosis suggesting a paracrine secretion of TGF-ß.23 Although PSCs produce TGF-ß1 autonomously, whether it has an autocrine effect in the regulation of matrix homeostasis is a crucial unanswered question.24 If autocrine expression occurs, it is likely to be important to TGF-ß-regulated gene expression because of the high local concentration of the cytokine in the extracellular milieu adjacent to secreting cells.
In this study, we have analyzed the expression of MMP-2, MT1-MMP, TIMP-1, and TIMP-2 in vivo during chronic pancreatitis in archival human pancreatic resections. We demonstrate production of TGF-ß by PSCs and show that TGF-ß1 influences PSC proliferation, collagen 1 expression, MMP-2, MMP-3, and MMP-9 in an autocrine manner.
|
Materials and Methods |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
Chemicals were obtained from the following sources: Hanks’ balanced salt solution (HBSS), Dulbecco’s modified Eagle’s medium (DMEM), fetal calf serum (FCS), penicillin, and streptomycin were from Gibco Life Technologies (Paisley, UK); and pronase, collagenase P, and deoxyribonuclease were from Roche Diagnostics (Mannheim, Germany).
Monoclonal antibodies for immunostaining of the pancreatic tissue were provided for MMP-2 by Calbiochem CN Biosciences (Nottingham, UK), for TIMP-1 by Chemicon International Ltd. (Harrow, UK), and for TIMP-2 by Santa Cruz Biotechnology. Antibodies to -SMA for Western blotting were provided by Sigma (Poole UK) for MMP-3 and MT1-MMP and by Chemicon International Ltd. TGF-ß1, neutralizing antibody to pan-TGF-ß, and neutralizing antibody to TGF-ß1 were provided by R&D Systems (Abingdon, Oxon, UK); CLPS collagenase was from Worthington Biochemical Corporation (Lakewood, NJ); Picogreen dsDNA quantification reagent was from Molecular Probes, Eugene, OR); and 3H-thymidine, 3H-proline, and 32P-ATP were from Amersham International (Amersham, UK). All other immunochemicals were from Sigma, and molecular biology grade reagents were from Promega (Southampton, UK).
Pancreatic Stellate Cell Extraction and Culture
Rat PSCs were extracted by a modification of the method described.2 Briefly, the dissected pancreas was finely minced and placed in a solution of HBSS with pronase (0.05%) and collagenase P (0.03%). The pancreas in the digest solution was shaken for 30 minutes at 37°C. The digested tissue was then filtered through nylon mesh and deoxyribonuclease (0.1%) was added. The cell suspension was centrifuged to obtain a pellet that was then resuspended with Optiprep 12% v/v (Sigma) and placed into centrifuge tube with a layer of HBSS placed on top. This was centrifuged for 20 minutes at 2000 rpm at 4°C. The stellate cells were collected from the band between the Optiprep/HBSS interface. After washing with HBSS once, the isolated cells were counted using a hemocytometer and the viability was assessed by trypan blue. Cells were plated onto plastic culture flasks and onto Nunc-chamber slides and maintained in 16% fetal calf serum in DMEM and antibiotics at 37°C in a humidifying incubator with 5% CO2.
RNA Extraction
RNA from cultured rat PSCs was extracted with a proprietary kit (RNAeasy, Qiagen, Crawley, UK) according to the manufacturer’s instruction. Extracted RNA was quantified by absorbance spectrometry at 260 nm and the integrity of the preparation was confirmed by the demonstration of undegraded 28S and 18S ribosomal bands after electrophoresis on a 1% agarose gel and ethidium bromide staining.
Northern Analysis
Ten µg of total RNA from passaged rat PSCs was separated by electrophoresis on a 1% agarose denaturing gel and transferred to Hybond N-nylon membranes with vacugene pump (Amersham International). The PSC-RNA bound to the nylon membranes were hybridized with the 32P-ATP labeled cDNA probe overnight before being subjected to stringency washes and autoradiography exactly as previously described.10
Collection of Conditioned Media
Passaged PSCs cultured in serum-containing media were washed three times in serum-free DMEM and left in this media for an hour after the final wash. The cells were incubated in fresh serum-free media containing antibiotics and 0.01% bovine serum albumin for 24 hours or 48 hours. In experiments to examine the effects of exogenous agents either TGF-ß1 (0.1, 1, 10 ng/ml) or neutralizing antibody to pan-TGF-ß (20 µg/ml), were included to the conditioned media. The media were then collected at the specified time points and frozen at -20°C until used for subsequent analysis.
Zymography for MMP-2 and MMP-9
PSC-conditioned media were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis on gelatin-containing acrylamide gels (8% acrylamide and 0.1% gelatin) under nonreducing conditions. After electrophoresis, gels were washed three times in 2.5% Triton X-100 for 10 minutes to remove the sodium dodecyl sulfate. After rinsing the gels in water, they were incubated overnight in 37°C in proteolysis buffer (50 mmol/L Tris/HCl, pH 7.8, 50 mmol/L CaCl2, 0.5 mol/L NaCl). The gels were stained with Coomassie brilliant blue (0.5% Coomassie blue, 50% methanol, 10% acetic acid) for 30 minutes. The gels were destained with 10% acetic acid/10% methanol until zones of proteolysis had cleared. Gelatinolytic activity appeared as colorless zones against a blue background.
Western Analysis for -SMA, MT1-MMP, and MMP-3
-SMA and MT1-MMP Western analysis used PSCs (passages 2 to 3) protein lysates whereas conditioned media were used in the MMP-3 Western analysis. Protein content of lysates or conditioned media was determined by a commercially available kit bicinchoninic acid protein assay (Sigma). Equivalent protein quantities were then size-fractionated on 10% sodium dodecyl sulfate-polyacrylamide gel. The separated samples were transferred to polyvinylidene difluoride membranes that were blocked with 500 mmol/L NaCl, 100 mmol/L Tris (pH 7.5), 0.1% Tween-20 (TTBS) containing 5% low-fat milk for 1 hour. The membrane was washed twice in TTBS and the membranes incubated overnight with monoclonal anti-mouse -SMA antibodies (1:500 dilution) (Sigma), polyclonal anti-rabbit MT1-MMP antibodies (1:2000 dilution) and polyclonal anti-rabbit MMP-3 antibodies (1:2500). After a TTBS wash, the membranes were incubated for 1 hour in 1:2000 dilution of horseradish peroxidase-conjugated anti-mouse antibody for -SMA and 1:3000 dilution of horseradish peroxidase-conjugated goat anti-rabbit antibody for MT1-MMP and MMP-3 (Dako, Cambridgeshire, UK). The membranes were developed using a commercial ECL detection system (Promega).
Immunolocalization of MMP-2, MT1 MMP, TIMP-1, and TIMP-2 in Samples of Normal and Chronic Pancreatitis
Six samples of normal pancreas were obtained either from the pancreatic resection margin at pancreatectomy for small pancreatic neoplasms or from pancreas resected as a result of extensive resection for nonpancreatic disease. In each case, routine histology had confirmed the absence of inflammation, pancreatic duct dilatation, or abnormal fibrosis in these tissues. In addition, six samples of pancreas from patients with chronic pancreatitis were obtained at pancreatic resection. Sequential sections from each sample were deparaffinized and subjected to pronase digestion for antigen retrieval before being immunostained. Sections were then washed in Tris-buffered saline (TBS), pH 7.6, before the addition of the primary antibodies at optimal dilutions as follows: -SMA (1:40,000), MMP-2 (1:100), MT-MMP (1:400), TIMP-1 (1:200), and TIMP-2 (1:400). For negative controls, the primary antibody was replaced with nonimmune IgG and TBS alone. After incubation with the primary antibodies, sections were washed in TBS (3 x 5 minutes) and incubated with biotinylated anti-mouse antiserum (Roche Diagnostics) for 30 minutes. Sections were washed as before, then incubated with streptavidin complexed with biotinylated horseradish peroxidase (DAKO, Abingdon, Oxon, UK) for 30 minutes. After washing with TBS as described above, sections were exposed to 3',3'-diaminobenzidine (Sigma) for 8 minutes, followed by TBS rinse. Finally the sections were counter-stained in Harris’ hematoxylin, dehydrated through graded alcohol, and mounted.
Determination of Cell Proliferation in Response to TGF-ß1 and Neutralizing Antibody to TGF-ß
Cultured rat PSCs (passages 2 to 4) were passaged onto 24-well plates. Cultured PSCs were incubated in DMEM with 0.5% FCS for 24 hours then exposed to the following treatments: TGF-ß1 (0.1, 1, 10 ng/ml) and neutralizing antibody to pan-TGFß (4, 20 µg/ml) with a positive control (5% FCS and DMEM) and negative control (0.5% FCS and DMEM) for 24 hours. A positive control of 5% FCS was included in all of the experiments to ensure that the cells had a normal proliferative response (data not shown). PSCs were pulsed with 3H-thymidine for 16 hours (1 µCi/well). At harvest, the cells were washed with cold HBSS and fixed with ice-cold absolute methanol and incubated at -20°C overnight. After three washes with HBSS (15 minutes each) on ice, 500 µl of cell dissolution solution (0.25 mol/L NaOH and 0.2% sodium dodecyl sulfate) was added into each well followed by 30 µl of 5 N HCl after 15 minutes. The mixture was transferred to the scintillation vials with 3 ml of scintillant. The radioactivity of the samples was measured using a Wallac 1217 Rackbeta liquid scintillation counter.
Determination of Collagen Synthesis in Response to TGF-ß1 and TGF-ß-Neutralizing Antibodies
PSCs cultured on 12-well plates were washed three times with HBSS and treated with TGF-ß1 (1, 10 ng/ml), neutralizing antibody to pan-TGF-ß (20 µg/ml), neutralizing antibody to TGF-ß1 (10 µg/ml) in media containing ascorbic acid (25 µg/ml), bovine serum albumin (0.01%), and DMEM for 24 hours. Nonimmune IgG (20 µg/ml) or conditioned media minus treatment were used are negative controls. After 24 hours of treatment, 3H proline at a concentration of 1 µCi per well was added for a further 24 hours. At the end of the incubation period, all supernatants were collected into centrifuge tubes. The plates of cells were kept at -20°C for DNA analysis using Pico-green. Aliquots of supernatants were plated as 100-µl quadruplicates per condition onto 96-well plate. Two aliquots per condition were incubated with collagenase solution (containing 50 mmol/L N-ethylmaleimide and 0.2 mol/L Tris/0.3 mol/L CaCl2) and the other two aliquots were incubated with the same solution in the absence of collagenase for 90 minutes at 37°C. After the incubation, each aliquot was washed with ice-cold 50% TCA to precipitate the protein and then the plate was then left on ice for 1 hour. The plate was washed with 10% TCA and then left to dry at room temperature. Once dried, 50 µl of scintillant was added to each well and the radioactivity was counted by ß-scintillation counting (Wallac 1450 Microbeta). The incorporation of 3H proline into collagen synthesized by PSCs was calculated by comparing the degraded (collagenase-containing) with the nondegraded (collagenase-free) values expressed per µg of DNA determined according to the manufacturer’s instruction. (Picogreen dsDNA quantification reagent, Molecular Probes).
Reverse-Transcriptase-Polymerase Chain Reaction (RT-PCR)
One µg of total RNA was reverse-transcribed using random hexamer primers. The integrity of the resultant cDNA was confirmed by PCR using primers for the housekeeping gene ß-actin. The primers used to amplify ß-actin were: 5'-TGT ACG TAG CCA TCC AGG CT and 5'-TTC TTC AGG GAG GAA GAG GA in the presence of 1 mmol/L MgCl2. PCR was performed for 35 cycles in the following temperature profile: 94°C, 20 seconds; 54°C, 30 seconds; 72°C, 1 minute, final extension at 72°C for 10 minutes. Rat TGF-ßRI (680 bp) was amplified and detected using primers: 5'-CGT CTG CAT TGC ACT TAT GC and 5'-CTG TGG CAG AAT CAT GTC TC. PCR was performed in the following conditions: 95°C, 30 seconds; 60°C, 15 seconds; 72°C, 10 seconds; final extension at 72°C for 10 minutes. Rat TGF-ßRII (650 bp) primers were: 5'-CAC TGT CCA CTT GTG ACA AC and 5'-GGT CTC AAA CTG CTC TGA AG; PCR was performed using the following conditions: 95°C, 30 seconds; 50°C, 15 seconds; 72°C, 10 seconds; final extension at 72°C for 10 minutes. The products of amplification reactions were separated by agarose gel electrophoresis and visualized by ethidium bromide staining. For each of the RT-PCR procedure negative controls were included.
Detection of Latent and Active TGF-ß1 Using Enzyme-Linked Immunosorbent Assay (ELISA)
Latent and activated TGF-ß1 was detected in PSC-conditioned media using a commercially available ELISA kit entirely according to the manufacturer’s instruction. (R&D, Abingdon, Oxon, UK)
Statistical Analysis
Student’s paired t-tests were used to compare the significance of differences between data. Values of P < 0.05 were considered statistically significant.
|
Results |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
One to two million PSCs were isolated per pancreas (n = 5). Viability of PSCs, assessed by trypan blue exclusion, was >80%. Activated PSCs were found to express the myofibroblastic marker -SMA by Western analysis and immunocytochemistry (Figure 1, A and B)
. -SMA was observed in all cells, suggesting that nonmyofibroblastic pancreatic cells were not present as contaminants.
|
-SMA, Procollagen Type 1, MMP-2, TIMP-1, and TIMP-2
By Northern analysis, the mRNA for -SMA, procollagen type 1, MMP-2, TIMP-1, and TIMP-2 were readily detectable in total RNA extracted from two independent cultures of passaged PSCs. In each case a single hybridization signal was obtained of the reported molecular size. TIMP-2 mRNA was detected at 1 kb and 3.4 kb which is in accord with previous reports of splice variants for this transcript25
(Figure 2)
. -SMA mRNA was detected at 1.8 kb in both PSC samples.
|
To examine PSC expression of MT1-MMP, protein lysates from passages 2 to 4 rat PSCs (PSC1 and PSC2) (n = 4) and one population of passage 3 human PSCs (PSC3) were subjected to Western analysis as described (Figure 3)
. A single signal of the reported molecular weight of 45 kd for MT1-MMP was observed. This confirms the presence of activated MT1-MMP as previously described in hepatic stellate cells.26
|
To confirm that the pattern of MMP and TIMP expression observed in activated PSCs reflected expression by these cells in injured and fibrotic pancreas, six cases of chronic pancreatitis and six normal controls underwent immunohistochemical staining for MMP-2, MT1-MMP, TIMP-1, TIMP-2, and -SMA. All of the normal controls showed expression of MMP-2, MT1-MMP, TIMP-1, and TIMP-2 within the periductal and perivascular connective tissue. In contrast, all of the chronic pancreatitis cases exhibited intense MMP-2, MT1-MMP, TIMP-1, and TIMP-2 expression within the areas of abnormal peri- and intra-acinar fibrosis. These areas of abnormal fibrosis also showed clear localization of -SMA consistent with activated PSCs being the source of these proteins. (Figure 4)
.
|
Northern analysis showed procollagen type I mRNA was detected in activated PSCs. However, addition of TGF-ß1 (10 ng/ml) to PSCs for 24 hours up-regulated collagen I expression by 69 ± 9% relative to untreated cells (control) (P < 0.05; n = 3). Representative data from one of these PSC preparation are shown (Figure 5A)
. As net production of collagen protein by PSCs might be influenced by concurrent expression of MMPs and TIMPs (Figure 2)
, the mRNA studies were complemented by studies of collagen protein production, using 3H-proline incorporation assay. These studies showed that TGF-ß1 (10 ng/ml) significantly increased the amount of collagen protein production by 34 ± 7% above the control (Figure 5B)
. The addition of neutralizing antibody to pan-TGF-ß1, -ß2, and -ß3 isoforms and neutralizing antibody to TGF-ß1 to passaged PSCs resulted in significantly reduced collagen synthesis, by 56 ± 12% and 40 ± 5%, respectively, relative to cells treated with nonimmune IgG (control) (n = 6).
|
TGF-ß1 Reduces PSC Proliferation
By 3H-thymidine incorporation, the rate of proliferation of passaged PSCs was significantly reduced by 36 ± 9%, 44 ± 10%, and 44 ± 7%, respectively, relative to control after the addition of exogenous TGF-ß1 (0.1, 1, 10 ng/ml) to PSCs for 24 hours (n = 10) (Figure 6)
. Addition of pan-neutralizing antibody to TGF-ß, -ß2, and -ß3 (20 µg/ml) increased the rate of proliferation by 40 ± 8% (P < 0.005).
|
We investigated the expression of both the latent and active form of TGF-ß1 by PSCs using ELISA. Latent TGF-ß1 production by PSCs was 1076 ± 225 pg/ml/24 hours and the amount of active TGF-ß1 was 42 ± 8 pg/ml. The percentage of TGF-ß1 present in the active form consistently represented a small proportion of the total ranging between 2 to 5% (n = 6). After 48 hours of incubation in serum-free media there was no significant increase in the amount of latent or active TGF-ß1 present in the PSC culture (Figure 7, A and B)
.
|
.
|
Western blotting showed that TGF-ß1 (1, 10 ng/ml) significantly down-regulated MMP-3 concentration in conditioned media by 23 ± 4% and 34 ± 5% (Figure 9, A and B)
. Gelatin zymography demonstrated that TGF-ß1 significantly down-regulated MMP-9 by 54 ± 2% whereas; neutralizing antibodies to TGF-ß1 significantly increased MMP-9 expression. Gelatin zymography also showed the expression of MMP-2 by PSCs, but exogenous TGF-ß1 did not alter its expression (Figure 10, A and B)
.
|
|
|
Discussion |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
We examined MMP-2 and MMP-9 expression by zymography and demonstrated that PSCs secrete MMP-2 exclusively as its inactive proform of 72 kd. Like all metalloproteinases MMP-2 requires activation by removal of its N-terminal.9 The major mechanism mediating the first stage of this activation has recently been defined and demonstrated to require proteolytic cleavage of MMP-2 by MT1-MMP. The cleavage of the propiece is achieved via a trimolecular complex in which TIMP-2, bound to pro-MMP-2, facilitates the interaction with MT1-MMP on the cell surface.26,30,31 We have further demonstrated that activated PSCs express MT1-MMP and TIMP-2 and therefore should have the capacity to activate MMP-2, and the lack of detectable activated MMP-2 was unexpected, especially as we have shown that both 66-kd- and 62-kd-activated forms are readily detectable in cultures of transformed hepatic stellate cells.26 Nonethe-less, the observation of MMP-2 secretion by PSCs is important as fibrotic disorders in other organs are also characterized by increased expression of MMP 2,32-37 thus MMP-2 may be a common marker of myofibroblast activation in fibrotic tissues. It has further been suggested that MMP-2 might contribute to fibrosis because it is a mitogen for mesangial cells and hepatic stellate cells26,38 and that the persistent remodeling of pericellular matrix by MMP-2 may be profibrotic by disrupting cell/matrix interactions that is normally keeping a check on proliferation.26,39
We have demonstrated that PSCs in both tissue culture models and in vivo during fibrosis are sources of TIMP-1 and TIMP-2. As described above, TIMP-2 is required for the activation of pro-MMP-2 by MT1-MMP. However in the presence of excess TIMP-2, MT1-MMP becomes inhibited and MMP-2 is not activated. Both TIMP-1 and TIMP-2 have potent inhibitory effects on all activated MMPs including those with interstitial collagenase activity (MMP-1 and MMP-13). TIMP production by PSCs might therefore promote fibrogenesis by preventing collagen degradation, which would contribute to fibrosis in chronic pancreatitis. With regards to collagen degradation, it is important to recognize that both MT1-MMP and MMP-2 have been reported to have collagenase activity,35
although they are also subjected to TIMP inhibition. The clear localization of TIMP-1 and TIMP-2 to the areas of fibrosis in each example of chronic pancreatitis suggests that these proteins are being expressed by activated PSCs. Further support for this was derived from our studies on serial sections of each example, demonstrating that these areas were populated by -SMA-positive cells. These data therefore reinforce and give biological relevance to the observations that we have made in tissue culture. TIMP expression in vivo appears to be localized to the area in which matrix is being laid down.
TGF-ß1 has been shown to have a profibrotic role in a variety of organs including liver, skin, and kidneys.11-14 Our studies indicate that to this list we can now add a role for TGF-ß1 in the fibrosis of chronic pancreatitis. Previous studies have emphasized the role of TGF-ß1 in pancreas injury and fibrosis.40 There is an increase of TGF-ß within 24 hours of pancreatic injury and during recovery from pancreatitis. The expression of TGF-ß is enhanced in the acinar and stromal cells of rat pancreas, highlighting the role of TGF-ß1 in the extracellular matrix remodeling after pancreatic injury.40 Moreover, in human chronic pancreatitis tissue, expression of TGF-ß1 and TGF-ß receptor I and II have been demonstrated.41 Previous studies have emphasized the role of TGF-ß1 as a paracrine mediator23,40,42 but our work demonstrates that the autocrine effect of TGF-ß1 may regulate PSC response to pancreatic injury. We have demonstrated that PSCs produce latent and active TGF-ß1 and, by demonstrating that these cells possess TGF-ß receptors, we suggest that TGF-ß1 has an autocrine effect on PSCs. This is confirmed by the observation that inhibition of TGF-ß1 in PSC cultures, using neutralizing antibodies, results in a decrease in collagen secretion and an increase in PSC proliferation. Exogenous TGF-ß1 also increased the expression of procollagen type 1 at the mRNA level and production of collagen protein assessed using 3H-proline incorporation assay. It was noted that the increase in collagen protein was less than that of the mRNA levels. However collagen I is subjected to extensive posttranscriptional regulation,43 which might lead to a poor correlation between mRNA and protein expression. It was important to show that net collagen protein deposition was increased as PSCs also concurrently produce MMP-2, MMP-3, MMP-9, and MT1-MMP, which enhance collagen degradation. Our studies suggest that TGF-ß1 promotes fibrogenesis not only by increasing collagen production but also by inhibiting MMPs in the pathway of collagen degradation.
TGF-ß1 reduces the expression of MMP-3 as well as MMP-9 although has little effect on MMP-2. Initial cleavage of mature collagen requires interstitial collagenase activity. A number of MMPs are known to have such activity including more recently MT1-MMP and MMP-2, both expressed by PSCs. MMP-3 activates the interstitial collagenase MMP-1, and MMP-9 is a gelatinase that mediates the breakdown of partly degraded collagen.7,8
Therefore, concurrent inhibition of MMP-3 and MMP-9 by TGF-ß1 would be expected to promote collagen accumulation (Figure 11)
. As previously reported for hepatic stellate cells, TGF-ß1 plays a role in repressing proliferation of PSCs. At face value this observation seems at odds with the known proliferation of the PSCs after pancreatic injury. However, within the pancreas in vivo, PSCs will be influenced by many cytokines and growth factors deriving from inflammatory and resident cells. These complex interactions are still poorly understood.
|
|
Footnotes |
|---|
Supported by the Digestive Disorders Foundation (Amelie Waring Training Fellowship to F. W. S.), the Mason Medical Trust, the Wessex Medical Trust, and the British Medical Research Council (Senior Clinical Fellowship to J. P. I.).
D. R. F. and J. P. I. contributed equally to the design and supervision of this work.
Accepted for publication February 18, 2002.
|
References |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
This article has been cited by other articles:
 |
|
 |
|
  J. A. Conti, T. J. Kendall, A. Bateman, T. A. Armstrong, A. Papa-Adams, Q. Xu, G. Packham, J. N. Primrose, R. C. Benyon, and J. P. Iredale The Desmoplastic Reaction Surrounding Hepatic Colorectal Adenocarcinoma Metastases Aids Tumor Growth and Survival via {alpha}v Integrin Ligation Clin. Cancer Res., October 15, 2008; 14(20): 6405 - 6413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vonlaufen, S. Joshi, C. Qu, P. A. Phillips, Z. Xu, N. R. Parker, C. S. Toi, R. C. Pirola, J. S. Wilson, D. Goldstein, et al. Pancreatic Stellate Cells: Partners in Crime with Pancreatic Cancer Cells Cancer Res., April 1, 2008; 68(7): 2085 - 2093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Asaumi, S. Watanabe, M. Taguchi, M. Tashiro, and M. Otsuki Externally applied pressure activates pancreatic stellate cells through the generation of intracellular reactive oxygen species Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G972 - G978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Aoki, H. Ohnishi, K. Hama, S. Shinozaki, H. Kita, H. Osawa, H. Yamamoto, K. Sato, K. Tamada, and K. Sugano Cyclooxygenase-2 is required for activated pancreatic stellate cells to respond to proinflammatory cytokines Am J Physiol Cell Physiol, January 1, 2007; 292(1): C259 - C268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Gao and D R Brigstock A novel integrin {alpha}5{beta}1 binding domain in module 4 of connective tissue growth factor (CCN2/CTGF) promotes adhesion and migration of activated pancreatic stellate cells Gut, June 1, 2006; 55(6): 856 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Aoki, H. Ohnishi, K. Hama, T. Ishijima, Y. Satoh, K. Hanatsuka, A. Ohashi, S. Wada, T. Miyata, H. Kita, et al. Autocrine loop between TGF-beta1 and IL-1beta through Smad3- and ERK-dependent pathways in rat pancreatic stellate cells Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1100 - C1108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. White, R. G. Atrasz, B. Hu, S. H. Phan, V. Stambolic, T. W. Mak, C. M. Hogaboam, K. R. Flaherty, F. J. Martinez, C. D. Kontos, et al. Negative Regulation of Myofibroblast Differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome 10) Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 112 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Hemers, C. Duval, C. McCaig, M. Handley, G. J. Dockray, and A. Varro Insulin-Like Growth Factor Binding Protein-5 Is a Target of Matrix Metalloproteinase-7: Implications for Epithelial-Mesenchymal Signaling Cancer Res., August 15, 2005; 65(16): 7363 - 7369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. O. Lee, J. L. Kang, and Y. H. Chong The Amyloid-{beta} Peptide Suppresses Transforming Growth Factor-{beta}1-induced Matrix Metalloproteinase-2 Production via Smad7 Expression in Human Monocytic THP-1 Cells J. Biol. Chem., March 4, 2005; 280(9): 7845 - 7853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Armstrong, G. Packham, L. B. Murphy, A. C. Bateman, J. A. Conti, D. R. Fine, C. D. Johnson, R. C. Benyon, and J. P. Iredale Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma Clin. Cancer Res., November 1, 2004; 10(21): 7427 - 7437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Ohnishi, T Miyata, H Ohnishi, H Yasuda, K Tamada, N Ueda, H Mashima, and K Sugano Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis Gut, October 1, 2003; 52(10): 1487 - 1493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P A Phillips, M J Wu, R K Kumar, E Doherty, J A McCarroll, S Park, R C Pirola, J S Wilson, and M V Apte Cell migration: a novel aspect of pancreatic stellate cell biology Gut, May 1, 2003; 52(5): 677 - 682. [Abstract] [Full Text]
|
|
|
|
|
|
P A Phillips, J A McCarroll, S Park, M-J Wu, R Pirola, M Korsten, J S Wilson, and M V Apte Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover Gut, February 1, 2003; 52(2): 275 - 282. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||
